pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 20·1 min read
save

Pandemics Should Be Treated as National Security Threats, Experts Argue

Jul 20, 2026·read at STAT ↗Positive

In an opinion piece, David Blumenthal and James A. Morone argue that pandemics should be classified and addressed as national security threats rather than solely health-care challenges.

They note that the U.S. Congressional Research Service defines national security broadly, covering economic welfare and supply-chain stability. By that measure, Covid-19, which caused over 1.2 million American deaths between 2020 and 2026 and disrupted the economy and education, rivals the death toll of all U.S. wars combined.

Treating pandemics as security issues, they say, would motivate reforms that strengthen preparedness, protect critical infrastructure, and reduce future devastation.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: It’s time to treat pandemics as threats to national security”

read at STAT ↗
1,534 words · retrieved Jul 20
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Moderna, Inc.RISING
drugs
Bio TObesityTestimVogelxonirmatrelvir + ritonavirtestosterone
topics
Vaccines5Infectious Disease2ObesityPsychiatry & CNSmRNA Therapeutic

related stories

  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • Jul 23Opinion: New billing codes likely to raise maternity care costsSTAT
  • Jul 21Opinion: Science and the public are learning the wrong lessons from CovidSTAT
  • Jul 20HHS vaccine committee quietly gets new charterSTAT
  • Jul 20Opinion: My husband’s suicide shows there’s something very wrong with the U.S. insurance industrySTAT